Connect Biopharma Holdings Ltd
NASDAQ:CNTB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Connect Biopharma Holdings Ltd
NASDAQ:CNTB
|
CN |
|
Advance Metals Ltd
ASX:AVM
|
AU |
|
M
|
Masisa SA
SGO:MASISA
|
CL |
|
ABCO Energy Inc
OTC:ABCE
|
US |
|
Witbe SA
PAR:ALWIT
|
FR |
|
Volvo AB
F:VOL1
|
SE |
|
Hyundai Glovis Co Ltd
KRX:086280
|
KR |
|
C
|
Credit Suisse Group AG
F:CSX
|
CH |
Wall Street
Price Targets
CNTB Price Targets Summary
Connect Biopharma Holdings Ltd
According to Wall Street analysts, the average 1-year price target for
CNTB
is 8.06 USD
with a low forecast of 6.06 USD and a high forecast of 10.5 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is CNTB's stock price target?
Price Target
8.06
USD
According to Wall Street analysts, the average 1-year price target for
CNTB
is 8.06 USD
with a low forecast of 6.06 USD and a high forecast of 10.5 USD.
What is Connect Biopharma Holdings Ltd's Revenue forecast?
Projected CAGR
-2%
The
compound annual growth rate
of Connect Biopharma Holdings Ltd's revenue for the next 4 years is
-2%.
